“a favorable trend”

In contrast, in patient aged ≥ 80 years, the OS benefit associated with maximal resection showed a favorable trend but did not reach statistical significance ( p = 0.11, Fig. 3 C).

A favorable trend toward levosimendan was observed in short-term (30-day) mortality; RRs ranged from 0.65 to 0.85, and our studies showed statistically significant results ( P < 0.05), suggesting a possible survival benefit during the acute phase.

In this regard, a temporal analysis of author productivity also highlights a favorable trend: persistence from top-tier investigators indicates the transition from initial mechanistic dabbling to established research programs with a firm footing in understanding cellular heterogeneity in kidney diseases.

Conversely, the RA pattern maintained a favorable trend towards risk reduction even among those with comorbidities (Hypertension: HR = 0.75; CKD: HR = 0.59), suggesting that regular physical activity may be necessary to be associated with lower risk in populations with compromised metabolic or renal health.

Corrected resampled t -tests confirm improved performance over the non-sequential Transformer, while the comparison with XGBoost indicates a favorable trend without conclusive evidence.

Although no head-to-head trials have directly compared these regimens, atezolizumab plus bevacizumab has demonstrated a favorable trend in the overall response rate (30.0% vs. 20.1%), median overall survival (19.2 vs. 16.4 months), and progression-free survival (6.9 vs. 3.8 months).

Subgroup results differed by modality; linked color imaging showed a favorable trend, but superiority remains unproven.

Although statistically significant results were obtained only for the BRCA1 gene, the VEGFA and SNCA still showed a favorable trend, probably due to the limitation of a small sample size.

92%, 86%, and 76% in the OVH group, respectively ( p = 0.070), showing a favorable trend in the EVH group.

The PIONEER-6 trial, although smaller and shorter in duration, confirmed the cardiovascular safety of oral semaglutide, showing a favorable trend toward reduced cardiovascular death.

A favorable trend for PRF1 A91V carriers treated with CHOP or cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone or prednisolone 14/21 was observed, with a 36-month EFS of 68% vs 50% ( P = .058) and significantly higher OS at 87% vs 60% ( P = .030; Figure 2 ).

The FP regimen demonstrated a favorable trend (HR = 0.68; 95% CI: 0.25–1.87), though not statistically significant, suggesting a need for further validation.

The combination of imlunestrant and abemaciclib did not demonstrate a confirmed OS benefit (HR 0.82; 95% CI, 0.59–1.16), but a favorable trend was observed [ 12 ].

Other interventions, such as TEII (SMD = 0.48) and TWDT (SMD = 0.37), also showed trends of being showed a favorable trend to the control group, but with wider confidence intervals and greater uncertainty.

Consistent with previous studies, 13 , 23 our data also confirm that ERAS does not impose additional burdens on liver reserve function - critical for hepatectomy patients, especially those with underlying liver diseases - supported by stable PALBI grade distributions and a favorable trend toward improved liver function.

34 In the TAKT study (Takayasu Arteritis Treated With Tocilizumab), a double-blind phase 3 RCT, there was a favorable trend toward tocilizumab over placebo for time to relapse, the primary end point; the relapse rate was higher in the placebo arm (53% versus 23%). 22 In the longer open-label follow-up in which all patients received tocilizumab for 96 weeks, disease stabilization was observed in 70% and improvement was seen in 20%. 35 One challenge is that routinely measured acute-phase reactants become unreliable indicators of disease flare in patients receiving tocilizumab.

The addition of durvalumab without olaparib (DBC) showed a favorable trend toward improved survival, albeit without statistical significance [ 9 ].

After adjustment for cross-trial differences, the MAIC results showed a favorable trend for momelotinib vs.

Although overall survival data remain immature, the median OS was not reached in the palbociclib arm compared with 77.0 months in the control arm (thus indicating a favorable trend that requires longer follow-up for confirmation [ 16 ]).

PFS showed a favorable trend but was not statistically significant (HR=0.69, 95% CI 0.42–1.14, p=0.15).

Interim analysis revealed a significant improvement in radiographic progression-free survival and a favorable trend in overall survival.

One can see that the major contribution of CPM on thermodynamic results is the adsorption behaviors, i.e., enhanced N 2 adsorption and weakened NH 3 desorption, which implies a favorable trend to proceed with eNRR. , Such positive influences are mainly observed on 4d and 5d dopants of Groups 6–8.

Our study demonstrated a reduced likelihood of IC+ infarction among patients with successful reperfusion and a favorable trend with good collateral circulation.

The analysis of gastric cancer-specific mortality, which included five trials of high methodological quality, showed a favorable trend but did not reach statistical significance (RR = 0.84; 95% CI: 0.62-1.12).

ACT scores showed a favorable trend in both groups, with a medium between-group effect size favoring the intervention (d = 0.42), although this did not reach statistical significance.